Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term HER-2. Found 4 abstracts

Li J, Gonzalez-Angulo AM, Allen PK, Yu TK, Woodward WA, Ueno NT, Lucci A, Krishnamurthy S, Gong Y, Bondy ML, Yang W, Willey JS, Cristofanilli M, Valero V, Buchholz TA. Triple-Negative Subtype Predicts Poor Overall Survival and High Locoregional Relapse in Inflammatory Breast Cancer. The oncologist. 2011 Dec;16(12):1675-83.   PMCID: not NIH funded
Freedman GM, Anderson PR, Li TY, Nicolaou N. Locoregional Recurrence of Triple-negative Breast Cancer After Breast-conserving Surgery and Radiation. Cancer. 2009 Jan;115(5):946-51.
Hayes DF, Thor AD, Dressler LG, Weaver D, Edgerton S, Cowan D, Broadwater G, Goldstein LJ, Martino S, Ingle JN, Henderson IC, Norton L, Winer EP, Hudis CA, Ellis MJ, Berry DA. HER2 and response to paclitaxel in node-positive breast cancer. New England Journal of Medicine. 2007 Oct;357(15):1496-506.
Sauter ER, Keller SM, Erner S, Goldberg M. HER-2/neu: A differentiation marker in adenocarcinoma of the esophagus. Cancer letters. 1993 Jan;75(1):41-4.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term HER-2

Last updated on Thursday, April 02, 2020